Insulet (PODD) Revenue (2010 - 2026)

Insulet's Revenue history runs 17 years deep, the most recent figure standing at $761.7 million for Q1 2026.

• Quarterly Revenue rose 33.87% year-over-year to $761.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (up 31.93% YoY) and the FY2025 annual result came in at $2.7 billion, up 30.73% from the prior year.
• Revenue was $761.7 million for Q1 2026 at Insulet, down from $783.8 million in the prior quarter.
• Across five years, Revenue topped out at $783.8 million in Q4 2025 and bottomed at $295.4 million in Q1 2022.
• A 5-year average of $502.6 million and a median of $488.5 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue gained 15.2% — and 2023, when it jumped 37.9%.
• Insulet's Revenue stood at $369.7 million in 2022, then soared by 37.9% to $509.8 million in 2023, then grew by 17.2% to $597.5 million in 2024, then soared by 31.18% to $783.8 million in 2025, then declined by 2.82% to $761.7 million in 2026.
• Business Quant data shows PODD's Revenue at $761.7 million in Q1 2026, $783.8 million in Q4 2025, and $706.3 million in Q3 2025.